Device
AMPLATZER™ PFO Occluder
AMPLATZER™ PFO Occluder is a medical device with 5 clinical trials. Currently 3 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
3(60%)
Results Posted
100%(2 trials)
Phase Distribution
Ph not_applicable
4
80%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
5
all time
Status Distribution
Active(3)
Completed(2)
Detailed Status
Active, not recruiting2
Completed2
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
3
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
recruiting120%
active_not_recruiting240%
completed240%
Recent Activity
3 active trials
Showing 5 of 5
recruitingnot_applicable
NobleStitch EL STITCH Trial is a PFO Comparative Trial
NCT04339699
active_not_recruitingnot_applicable
AMPLATZER PFO Occluder Post Approval Study
NCT03309332
active_not_recruiting
Amplatzer PFO Occluder Post-marketing Surveillance Study
NCT04349995
completednot_applicable
PREMIUM Migraine Trial
NCT00355056
completednot_applicable
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
NCT00465270
Clinical Trials (5)
Showing 5 of 5 trials
NCT04339699Not Applicable
NobleStitch EL STITCH Trial is a PFO Comparative Trial
NCT03309332Not Applicable
AMPLATZER PFO Occluder Post Approval Study
NCT04349995
Amplatzer PFO Occluder Post-marketing Surveillance Study
NCT00355056Not Applicable
PREMIUM Migraine Trial
NCT00465270Not Applicable
Patent Foramen Ovale Closure or Medical Therapy After Stroke - RESPECT Trial
All 5 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 5